Event
Inhibiteurs du FcRn et nouvelles options pour la myasth茅nie grave (anglais seulement)
Muscular Dystrophy Canada is pleased to present a webinar on the neonatal Fc receptor (FcRn) pathway for people with generalized myasthenia gravis (gMG). We are excited to have speaker, Dr Carolina Barnett Tapia, discuss next-generation treatments for myasthenia gravis, and help us understand how these treatments work in the neuromuscular pathway.
(脡v茅nement en anglais seulement)
听
